Cleared Traditional

K991831 - BMT ANSCORE HEALTH MANAGEMENT SYSTEM, MODEL 1.1

K991831 is an FDA 510(k) clearance for BMT ANSCORE HEALTH MANAGEMENT SYSTEM, manufactured by Boston Medical Technologies, Inc.. The device is a Class 2 Cardiovascular device with product code DPS cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K991831 · Boston Medical Technologies, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1999
Decision
14d
Days
Class 2
Risk

K991831 is an FDA 510(k) clearance for the BMT ANSCORE HEALTH MANAGEMENT SYSTEM, MODEL 1.1. Classified as Electrocardiograph (product code DPS), Class II - Special Controls.

Submitted by Boston Medical Technologies, Inc. (Wakefield, US). The FDA issued a Cleared decision on June 11, 1999 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2340 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Boston Medical Technologies, Inc. devices

FDA 510(k) Submission Details - K991831

510(k) Number K991831 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 28, 1999
Decision Date June 11, 1999
Days to Decision 14 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
111d faster than avg
Panel avg: 125d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DPS Device Classification - Class 2, Special Controls

Product Code DPS Electrocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

Intertek Testing Services

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DPS Electrocardiograph

All 472
Devices cleared under the same product code (DPS) and FDA review panel - the closest regulatory comparables to K991831.
GE MARQUETTE MEDICAL SYSTEMS PRUCKA CARDIOLAB CATH SYSTEM, VERSION 1.11
K000645 · General Electric Medical Systems Information Techn · May 2000
PRUCKA ENGINEERING INC. CARDIOLAB EP SYSTEM,VERSION 4.2
K993414 · Prucka Engineering, Inc. · Apr 2000
MARS UNITY WORKSTATION WITH HEART RATE VARIABILITY (HRV) OPTION
K991786 · General Electric Medical Systems Information Techn · Nov 1999
MONITOR ONE NDX
K972991 · Qmed, Inc. · Dec 1998
CAMBRIDGE HEART CH 2000 CARDIAC DIAGNOSTIC SYSTEM
K981697 · Cambridge Heart, Inc. · Oct 1998
MICROMEDICAL 12 LEAD SIMULTANEOUS CABLE
K974220 · Micromedical, Inc. · Aug 1998